Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
US10919854B2 · kind B2 · utility
2Cited by
16References
28Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 13, 2020 |
| Grant date | Feb 16, 2021 |
| Priority date | — |
| Expiry date | May 13, 2040 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to mono- or di-substituted indole compounds, methods to prevent or treat dengue viral infections by using the compounds and also relates to use of the compounds as a medicine, more preferably for use as a medicine to treat or prevent dengue viral infections. The present invention furthermore relates to pharmaceutical compositions or combination preparations of the compounds, to the compositions or preparations for use as a medicine, more preferably for the prevention or treatment of dengue viral infections. The invention also relates to processes for preparation of the compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.